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Abstract
 
HIV-1 pathogenicity factor Nef has been shown to modulate calcium signaling in host cells,
but the underlying molecular mechanisms have remained unclear. Here we show that calcium/
calcineurin-dependent activation of nuclear factor of activated T cells (NFAT) by Nef in Jurkat
T cells requires the endoplasmic reticulum-resident inositol trisphosphate receptor (IP
 
3
 
R), but
yet does not involve increase in phospholipase-C
 
 
 
1 (PLC
 
 
 
1)-catalyzed production of IP
 
3
 
 or
depletion of IP
 
3
 
-regulated intracellular calcium stores. Nef could be coprecipitated with en-
dogenous IP
 
3
 
R type-1 (IP
 
3
 
R1) from Nef-transfected Jurkat T cells as well as from HIV-
infected primary human peripheral mononuclear cells. Thus, the Nef/IP
 
3
 
R1-interaction
defines a novel T cell receptor–independent mechanism by which Nef can promote T cell ac-
tivation, and appears to involve atypical IP
 
3
 
R-triggered activation of plasma membrane calcium
influx channels in a manner that is uncoupled from depletion of intracellular calcium stores.
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Introduction
 
Nef is a 25–34 kD myristoylated protein of primate immu-
nodeficiency viruses (HIV-1, HIV-2, simian immunodefi-
ciency viruses [SIVs]), which plays an important role in the
pathogenesis of AIDS. The molecular mechanisms under-
lying the pathogenic effect of Nef are still incompletely un-
derstood, but several lines of evidence indicate involve-
ment of Nef-induced changes in the activity of cellular
signaling pathways. Nef has no enzymatic activity, and in-
stead functions as an adaptor bringing together different
host cells proteins. A large number of proteins, mainly pro-
tein kinases and components of endocytic trafficking ma-
chinery, have been reported to bind to Nef (1–3).
The ability of HIV to replicate in T cells is strongly in-
fluenced by T cell activation, which regulates both pre-
and postintegration steps in HIV life cycle (4, 5). Signifi-
cant experimental attention has therefore been directed to
address a possible role of Nef in T cell activation. Indeed, T
lymphocytes from transgenic mice show hyperresponsive
behavior suggesting that Nef can promote T cell activation
(6, 7).
Up-regulation of IL-2 expression and subsequent auto-
crine stimulation by this cytokine are hallmarks of T cell
activation. The transcription factor nuclear factor of acti-
 
vated T cells (NFAT)
 
*
 
 is a critical mediator of increased
IL-2 gene expression during T cell activation (8, 9). NFAT
is composed of a cytoplasmic NFAT core factor that trans-
locates to the nucleus upon dephosphorylation by the cal-
cium-regulated phosphatase calcineurin, and a preexisting
nuclear component (typically consisting of members of the
activator protein-1 [AP-1] family of transcription factors)
that is activated by the mitogen-activated protein kinase
(MAPK) cascade (8, 10). Binding of TCR to its ligand,
provided by an antigen-presenting cell or experimental ac-
tivation by TCR–cross-linking antibodies, results in activa-
tion of the MAPK-cascade and the Ca
 
2
 
 
 
/calcineurin path-
way. Thus, TCR engagement is sufficient to trigger both
of the major T cell signaling pathways required for activa-
tion of NFAT-mediated gene expression (8).
Stimulation of T cells via TCR initiates sequential acti-
vation of TCR-associated protein- and lipid kinases, which
leads to membrane localization and tyrosine phosphoryla-
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tion of phospholipase-C
 
 
 
1 (PLC
 
 
 
1) (11). This results in
increased catalytic activity of PLC
 
 
 
1, and thereby produc-
tion of diacylglycerol (DAG) and inositol 1,4,5-trisphos-
phate (IP
 
3
 
). IP
 
3
 
 binds to and activates inositol 1,4,5-tris-
phosphate receptor (IP
 
3
 
R), which functions as a calcium
channel controlling the release of calcium from intracellular
stores in the endoplasmic reticulum (ER) (12, 13). This re-
sults in a transient increase in free cytoplasmic calcium,
which in itself is insufficient to promote transcriptional ac-
tivation in T cells (14, 15). Instead, the depleted calcium
stores in the ER serve as a trigger that results in opening of
calcium channels in the plasma membrane, and thereby cal-
cium influx from outside of the cell (12, 13). This process is
known as capacitative calcium entry (CCE) or store-oper-
ated calcium entry (SOCE) (16, 17).
The identity of store-operated channels (SOCs) on the
plasma membrane has remained unclear. A recent report
(18) has provided substantial evidence suggesting that
CaT1, a Ca
 
2
 
 
 
 channel previously isolated from intestinal
cells (19), would be a SOC. However, other evidence sug-
gests that mammalian homologues of Drosophila Trp (tran-
sient receptor potential) may represent components of
these channels at least in some cell types (17). The SOC
found in T cells is called Ca
 
2
 
 
 
 release-activated calcium
channel (CRAC) (12, 13). A major open question in this
field concerns the nature of the signal generated by de-
pleted ER calcium stores to cause opening of SOCs/
CRACs. While some studies have suggested a diffusible
signaling factor (“calcium influx factor” hypothesis), a
number of recent findings favor an alternative hypothesis
known as “conformational coupling model,” which in-
volves direct physical communication between IP
 
3
 
R and
SOC/CRAC (12, 17).
The role of calcium metabolism in Ca
 
2
 
 
 
/calmodulin-
regulated, calcineurin-mediated activation of NFAT has
been elucidated in detail. These studies have established
that a sustained elevation in cytoplasmic free calcium,
which in nonexcitable cells such as T lymphocytes, is de-
pendent on calcium influx via CRACs, is necessary to keep
NFAT in the nucleus (15, 20). Engagement of the TCR
normally triggers a series of oscillating Ca
 
2
 
 
 
 spikes (12, 13).
Interestingly, the frequency of these spikes seems to be im-
portant for optimal NFAT activation, thus providing speci-
ficity to calcium-regulated signaling processes (21, 22). Be-
cause of the oscillating nature of these changes, NFAT can
be efficiently activated by only a small net increase in cyto-
plasmic calcium levels (21).
Recently, Simmons et al. demonstrated by gene expres-
sion profiling that expression of Nef in Jurkat T cells can
trigger a transcriptional program that is nearly identical to
that induced by anti-CD3 antibodies (23). Moreover, two
other studies have observed potentiation of TCR-triggered
activation of T cells by Nef, as measured by increased
NFAT-dependent gene expression and IL-2 secretion (24,
25). Because of the observed accumulation of Nef in lipid
rafts enriched in TCR-associated signaling proteins, it was
suggested that Nef could mediate this positive effect by fa-
cilitating interactions among these signaling proteins (25).
 
However, other studies have concluded that expression of
Nef either inhibits or has no effects on TCR-mediated ac-
tivation (26–31). The ability of Nef to cause downmodula-
tion of cell surface expression of important components of
the TCR complex, such as TCR
 
 
 
 chain and CD28, could
be one factor accounting for the differing results of these
studies (32, 33).
On the other hand, we have recently described an addi-
tional TCR-independent mechanism by which Nef can
contribute to T cell activation (34, 35). We found that acti-
vation of the MAPK-cascade alone was sufficient to cause a
robust activation of NFAT-dependent gene expression in
T cells expressing high levels of Nef. Studies in Lck-nega-
tive cells and experiments using dominant-negative expres-
sion constructs and inhibitory drugs indicated that this po-
tential of Nef to activate calcium signaling did not depend
on the TCR-associated signaling complex. In this study
we have examined the molecular mechanism underlying
TCR-independent activation of calcium signaling by Nef.
We found that this effect of Nef was strictly dependent on
cellular IP
 
3
 
R function, although it did not involve in-
creased IP
 
3
 
 production by PLC
 
 
 
1, nor depletion of the
IP
 
3
 
-sensitive intracellular calcium stores. These observa-
tions together with the ability of Nef to coprecipitate with
IP
 
3
 
R1 suggested that Nef, by interacting with IP
 
3
 
R1, trig-
gers an aberrant activation of CCE independently of the
filling state of intracellular calcium stores.
 
Materials and Methods
 
Plasmids and Antibodies.
 
The Nef, pLacZ, and NFAT-
luciferase plasmids used have been described earlier (34). PLC
 
 
 
1-
H335F and hemagglutinin (HA)-apoaequorin (Molecular Probes)
cDNAs were cloned into eF1
 
 
 
-promoter-driven vector (referred
to as pEBB; reference 34). pEGFP-NFATc1 was obtained from
Päivi Koskinen (University of Turku, Turku, Finland), pCMVI-
9-IP
 
3
 
R1 from Gregory A. Mignery (Loyola University of Chi-
cago, Chicago, IL) and pEGFP-N2/human muscarinic receptor 1
(hM1) from Karl Åkerman (University of Uppsala, Uppsala, Swe-
den). The cDNA encoding for a truncated CD8 molecule (extra-
cellular and transmembrane domains of human CD8 (amino acids
1–207) followed by two residues [I, D]) was generated by PCR
and cloned into pEBB. The HIV-1 NL4–3-derived proviral
Nef(
 
 
 
) and Nef(
 
 
 
) plasmids have been described previously
(36). SRE-luciferase reporter construct containing three copies of
consensus serum response factor/ternary complex factor binding
sites in front of a minimal promoter was obtained from Roya
Khosravi-Far (Harvard Medical School, Boston, MA). Anti-CD3
(HIT3a) antibody was purchased from BD PharMingen, anti-
IP
 
3
 
R1-antibody was from A.G. Scientific Inc., anti-CD8 (LT8)-
antibody was from Serotec, biotinylated goat anti–mouse IgG was
from DAKO, polyclonal Nef-antisera was provided by Mark
Harris (Leeds University, Leeds, UK), and monoclonal Nef-anti-
bodies by FIT Biotech.
 
Cell Lines, Transfections, and Luciferase Assays.
 
Jurkat (JE-6;
from American Type Culture Collection) and the J.IP
 
3
 
R1AS
(provided by Andrew Marks, Columbia University, New York,
NY) cells were maintained in complete RPMI 1640 (Hyclone)
supplied with 10% fetal calf serum (BioWhittaker). Every 2 to 3
mo, J.IP
 
3
 
R1AS cells were grown in the presence of 2 mg/ml of 
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Hygromycin B (Calbiochem) for 10 d. Human embryonic kid-
ney 293T cells (from American Type Culture Collection) were
maintained in complete DMEM (Hyclone; 10% serum) under
standard conditions. HEK293T cells were transfected with a
modified CaPO
 
4
 
-method as described previously (37). Jurkat and
J.IP
 
3
 
R1AS cells were transfected with either Fugene (Roche
Molecular Biochemicals) as described previously (34) or with
DMRIE-C reagent (GIBCO BRL/Life Technologies) accord-
ing to manufacturer’s instructions. In brief, DMRIE-C reagent
(2/3 ratio 
 
 
 
l DMRIE-C/
 
 
 
g DNA) was incubated in 500 
 
 
 
l of
OPTIMEM (GIBCO BRL/Life Technologies) for 45 min at
room temperature (RT). Exponentially growing cells were
washed once with OPTIMEM and were then resuspended into
OPTIMEM (15 
 
  
 
10
 
6
 
 cells/ml). 100 
 
 
 
l of cell suspension was
pipetted onto DMRIE-C/DNA mixture and incubated for 4 h
at 
 
 
 
37
 
 
 
C (5% CO
 
2
 
). 1 ml of complete RPMI-1640 containing
15% FCS was added and incubation was continued overnight.
20 h after transfection some of the cultures were stimulated for
4–5 h with 100 ng/ml PMA (Sigma-Aldrich), 50 ng/ml HIT3a,
or 30 nM thapsigargin (Alexis Biochemicals). When indicated,
500 
 
 
 
M EGTA (Sigma-Aldrich), 200 nm cyclosporin A (CsA;
Sigma-Aldrich), 30 
 
 
 
M SKF-96365 (Alexis Biochemicals), or 75
nM 2-aminoethoxydiphenyl borate (2-APB; Calbiochem) were
added to the cells 30 min before their stimulation. Luciferase ac-
tivities in these cells were determined and normalized to
 
 
 
-galactosidase activities measured from the same lysates as de-
scribed previously (34).
 
Confocal Microscopy of Green Fluorescent Protein–expressing Cells.
 
20 h after transfection 10
 
6
 
 Jurkat cells were resuspended into 30
 
 
 
l of RPMI-1640. An equal volume of prewarmed (
 
 
 
40
 
 
 
C) PBS
containing 1% (wt/vol) low melting point agarose (BDH Labora-
tory Supplies) was added, and a sample of this mixture was pipet-
ted between a glass slide and a coverslip resting on thin plastic
spacers. Fluorescence microscopy images were taken with an Ul-
traview confocal imaging system (PerkinElmer) using an Olym-
pus X70 microscope.
 
Flow Cytometric Analysis of Intracellular Calcium.
 
Petri dishes
were coated with anti–mouse IgG (10 
 
 
 
g/ml in 1 ml of 0.05 M
Tris-HCl pH 9.5) for 1 h at RT and washed three times with
PBS containing 5% FCS. 20 h after transfection of 3 
 
  
 
10
 
6 
 
Jurkat
cells with pEBB-CD8 (1–207; 1 
 
 
 
g) and Nef or a control vector
(3 
 
 
 
g), cells were incubated with 0.5 
 
 
 
g/ml of anti-CD8 for 30
min at RT, washed twice with PBS plus 5% FCS and pipetted
onto coated Petri dishes in 1 ml of PBS plus 5% FCS. Cells were
incubated for 45 min at RT and gently washed three times with
PBS plus 1% FCS. Bound cells (75–90% of which were transfec-
tion-positive as determined by parallel green fluorescent protein
(GFP)/CD8 transfection controls) were collected by pipetting,
washed twice with 800 
 
 
 
l of RPMI-1640 (without phenol red;
Hyclone), and loaded with 3 
 
 
 
M Fluo-3- and 5 
 
 
 
M Fura-Red-
acetomethylesters in the presence of 0.02% Pluronic F-127 (all
three from Molecular Probes) for 20 min at RT. Cells were
washed twice with RPMI-1640 (1% serum, without phenol red)
and suspended into 1 ml of this medium followed by an incuba-
tion at 
 
 
 
37
 
 
 
C, 5% CO
 
2
 
 for 20 min. The measurements were
performed in a Becton Dickinson FACScan™ cytometer (excita-
tion 488 nm).
 
Virus Production and Infections.
 
HEK293T cells were trans-
fected with 15 
 
 
 
g of either HIV-1 NL4–3-derived Nef(
 
 
 
) or
Nef(
 
 
 
) proviral plasmids by using a modified CaPO
 
4
 
 method
(37). 48 h after transfection, the virus-containing supernatants
were passed through 0.45-
 
 
 
m filters (Schleicher & Schuell) to re-
move cellular debris. Supernatants were either used immediately
 
or were frozen in aliquots at 
 
 
 
80
 
 
 
C. The supernatant p24 con-
centrations were determined by a p24 ELISA assay. Human
PBMCs were separated from buffy coats of healthy donors (Fin-
nish Red Cross blood transfusion service, Tampere) through Fi-
coll-Hypaque (Amersham Pharmacia Biotech) gradient cen-
trifugation. PBMCs were grown in complete RPMI-1640
supplemented with 2 U/ml of human IL-2 (R&D Systems).
Equal quantities (1,000 ng of p24) of Nef(
 
 
 
)HIV or Nef(
 
 
 
)HIV
virions were used to infect 20 
 
  
 
10
 
6 
 
PBMCs, which were lysed
5 d after the infection.
 
Detection of Nef and IP3R1.
 
20 h after transfection, 10 
 
  
 
10
 
6
 
Jurkat or J.IP
 
3
 
R1-AS cells transfected with 15 
 
 
 
g of Nef or an
empty control vector were washed with PBS and lysed in cell-
lysis buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 10% glyc-
erol, 1% Triton X-100, 1 mM EGTA, 1.5 mM MgCl
 
2
 
, 1 mM PMSF,
10 
 
 
 
g/ml approtinin). One fifth of the lysate was immunoprecip-
itated with polyclonal Nef-antisera and the rest with IP
 
3
 
R1 anti-
body. After three washes with cell-lysis buffer these immuno-
complexes were analyzed by Western blotting using a mixture of
monoclonal Nef antibodies as described previously (37). 5 d after
infection of 20 
 
  
 
10
 
6 
 
PBMCs with either Nef(
 
 
 
)HIV or
Nef(
 
 
 
)HIV or 24 h after transfection of HEK293T cells with 5
 
 
 
g of pEBB-Nef or an empty pEBB-vector together with 5 
 
 
 
g
of IP
 
3
 
R1 or a control vector, these cells were washed once with
PBS and lysed in 1 ml of cell-lysis buffer. The lysates were split in
two, the other half was immunoprecipitated with polyclonal
Nef antisera and the other with IP
 
3
 
R1 antibody followed by
Western blotting with anti-Nef or anti-IP
 
3
 
R1 antibodies as de-
scribed above.
 
Measurement of Intracellular Calcium by Apoaequorin.
 
20 h after
transfection of three million Jurkat cells with apoaequorin (3 
 
 
 
g)
and Nef or a control vector (1 
 
 
 
g), and in some cases an hM1
vector (1 
 
 g), these cells were incubated for 1–2 h in 500  l of
complete RPMI-1640 containing 2.5  M coelenterazine-h (Mo-
lecular Probes), washed twice with 800  l of RPMI-1640 (1%
serum, w/o phenol red), and suspended into 300  l of this me-
dium. Calcium-dependent light emission was continuously mon-
itored with a Luminova 1254 luminometer (Labsystems). During
measurements, 0.5 mM EGTA (Sigma-Aldrich), 2  M A23187
(Calbiochem), or 10  M carbachol (Calbiochem) was added as
indicated. At the end of each experiment the cells were lysed in
300  l of hypotonic lysis buffer (10 mM Tris-HCl, pH 7.2, 0.1
mM EGTA) followed by addition of 30 mM CaCl2 to measure
the remaining aequorin signal from each transfection. The total
aequorin signal measured during the experiment was used to nor-
malize for transfection efficiency (38).
Results
Nef Induces Nuclear Translocation of NFATc. We have
previously used a reporter gene construct driven by tan-
dem copies of the antigen receptor response element of
the IL-2 gene (ARRE2; reference 39) to reveal the poten-
tial of Nef to activate the transcription factor NFAT (34,
35). The effect of Nef on ARRE2-directed gene expres-
sion in Jurkat cells is demonstrated in Fig. 1 A. In agree-
ment with our previous findings, a 4-h treatment with the
MAPK cascade-activator phorbol 12-myristate 13-acetate
(PMA) alone was not sufficient to induce significant ex-
pression of the transfected NFAT reporter gene in control
vector-transfected Jurkat cells, whereas in Nef-expressing1026 Nef and T Cell Calcium Signaling
cells the same treatment resulted in efficient activation of
luciferase expression. This effect was abolished if 500  M
EGTA or 200 nM CsA was added into these cultures be-
fore PMA, indicating that it involved influx of extracellu-
lar calcium and action of calcineurin (Fig. 1 A). Similarly,
pretreatment of cultures with another calcineurin inhibi-
tor, FK506, led up to 99% inhibition of Nef plus PMA-
mediated activation of NFAT-driven transcription (data
not shown).
To further validate the ARRE2-directed transcriptional
study system as a read-out for Nef-induced changes in cal-
cium signaling, and to exclude the possibility that also the
activity of Nef itself might depend on PMA stimulation,
we examined the ability of Nef to induce nuclear transloca-
tion of green fluorescent protein (GFP)-tagged NFATc1
(NFAT2) in the absence of MAPK activation. As shown
in Fig. 1 B, in majority of Nef-expressing Jurkat cells
NFATc1-GFP was found in the nucleus, whereas in con-
trol cells it was mainly cytoplasmic. Like NFAT-dependent
gene expression (Fig. 1 A), Nef-induced nuclear transloca-
tion of NFATc1-GFP was abrogated by CsA-treatment
(cytoplasmic localization in  95% of treated cells, data
not shown). Moreover, chelating extracellular Ca2  with
EGTA or addition of 30  M of SKF-96365, a widely used
inhibitor of Ca2 -influx via store-operated and receptor-
gated Ca2  channels (40), also led to complete reversal of
the Nef-induced nuclear NFATc1-GFP fluorescence (data
not shown). These findings confirmed that the NFAT-acti-
vating function of Nef requires Ca2  influx, and implicated
CRAC channels in this process.
To directly visualize the increased intracellular calcium
level that promotes nuclear localization of NFAT in Nef-
expressing cells, we enriched the Jurkat cells transfected
with Nef or the control vector by a panning strategy based
on a cotransfected extracellular tag, and double-loaded this
subpopulation of cells with calcium fluorophores Fluo-3
and Fura-Red. As shown in Fig. 1 C, a modest but obvious
shift (toward the lower right quadrant) indicative of higher
intracellular calcium levels was indeed observed in Nef-
transfected cells compared with identically processed cells
transfected with the control vector. Due to the greater sen-
sitivity of Fluo-3 as compared with Fura-Red this shift was
more apparent in the x- than the y-axis. The fact that this
relatively small apparent increase in intracellular calcium is
able to efficiently activate NFAT is in good agreement
with previous studies that have established NFAT as a sen-
sitive marker for small and oscillating increases in cytoplas-
mic free Ca2  levels (21, 22).
PLC 1 Is Not Involved in Regulation of Calcium Signaling
by Nef. During normal T cell activation the elevated lev-
els of IP3 that trigger calcium influx via CCE are caused by
increased activity of PLC 1 (12, 13). To examine if the ef-
fect of Nef on calcium signaling was mediated via PLC 1-
catalyzed IP3 production, we constructed a vector for over-
expression of a dominant negative mutant of PLC 1
(PLC 1-H335F, dubbed as PLC-DN). A similar mutant
has previously been successfully used to examine the role of
the catalytic activity of PLC 1 in serum-induced DNA
Figure 1. Calcium/calcineurin-dependent activation of NFAT by Nef.
(A) Relative increase in NFAT-dependent luciferase expression in Jurkat
cells cotransfected either with an empty control vector or Nef. 20 h later
some of the cultures were pretreated with EGTA or CsA for 30 min be-
fore 4 h stimulation with PMA as indicated. Luciferase values normalized
based on a cotransfected  -galactosidase vector are shown relative to the
value from untreated control-transfected cells, which was set to one. The
data are mean values from two independent transfection experiments per-
formed in duplicate, and the standard error bars indicate variation among
these four samples. (B) Fluorescence confocal microscopy of Jurkat cells
transfected with a GFP-tagged NFATc1 together with an empty control
vector or Nef. The percentages of cytoplasmic/nuclear localization of
GFP-NFATc1 indicated represent data from three independent experi-
ments in which a total of 70 GFP-positive cells from each sample were
scored. (C) Flow cytometric analysis of intracellular calcium in control-
or Nef-transfected Jurkat cells. Transfected Jurkat cells were enriched by
panning and loaded with Ca2 -indicator dyes Fluo-3 and Fura-Red as
described in Materials and Methods. Elevated Ca2 -levels enhance the
Fluo-3 fluorescence but decrease the Fura-Red fluorescence. The data
shown is representative of six independent transfection experiments.1027 Manninen and Saksela
synthesis (41) and in TCR-mediated signaling (42). Cotrans-
fection of PLC-DN with an NFAT-dependent reporter
plasmid into Jurkat cells efficiently inhibited TCR-medi-
ated activation of NFAT triggered by an anti-CD3 anti-
body (Fig. 2 A). This result was in agreement with recent
data on Jurkat cells lacking PLC 1 expression (42) and on
B cells of PLC 2-deficient mice (43), and confirmed the
feasibility of this approach for inhibition of PLC 1-cata-
lyzed IP3 production in transiently transfected Jurkat cells.
As expected, the inhibition of NFAT activation by PLC-
DN could be bypassed by costimulation of cells with PMA
and the calcium ionophore A23187 (data not shown), which
activate MAPK- and calcium signaling downstream of
PLC 1. As shown in Fig. 2 B, the effect of Nef was also
found to be downstream of PLC 1, because cotransfection
of PLC-DN had no inhibitory effect on Nef plus PMA-
induced NFAT activation. Thus, we concluded that activa-
tion of calcium signaling by Nef was not due to increased
IP3 production caused by action of Nef on PLC 1 or its
upstream regulators.
Nef-induced Calcium Signaling Depends on IP3R1 Func-
tion. The observed IP3 independence of NFAT activation
by Nef suggested that Nef might act directly on the cellular
machinery involved in calcium influx via CCE. To charac-
terize the target of Nef in this system we used a recently
described cell-permeable IP3R-inhibitor 2-APB (44, 45).
IP3R is centrally positioned in the CCE apparatus because,
in addition to binding to IP3, it serves as a calcium release
channel in ER and may also be physically involved in the
coupling step between calcium release and influx (45–47).
As expected, 2-APB efficiently blocked NFAT activation
triggered by TCR stimulation (Fig. 3 A). Strikingly, 2-APB
was also a potent inhibitor of Nef-induced NFAT ac-
tivation (Fig. 3 A). To exclude the possibility that this inhi-
bition might have involved nonspecific effects by 2-APB,
such as toxicity or interference with PMA-induced MAPK
activation, we examined the effect of 2-APB on PMA-
stimulated luciferase expression in Jurkat cells transfected
with a serum response element (SRE)-driven reporter con-
struct. In contrast to the complete inhibition of the anti-
CD3- and Nef plus PMA-induced NFAT activation (96
and 98%, respectively), PMA-stimulated SRE-dependent
luciferase expression was only modestly (34%) reduced by
2-APB treatment (data not shown). Moreover, because
regulation of SRE is complex, it is possible that also this
small inhibition was caused, at least in part, by specific ac-
tion of 2-APB on IP3R.
Figure 2. Effect of overexpression of a dominant-negative PLC 1 mu-
tant on NFAT activation by TCR-stimulation or Nef expression. (A)
Jurkat cells were cotransfected with the NFAT reporter plasmid together
with an empty control vector or a PLC 1-H335F-expression plasmid
(PLC-DN). 20 h after transfection cells were either left untreated or stim-
ulated for 5 h with an anti-CD3 antibody (anti-CD3). Luciferase activities
relative to the untreated control-transfected cells are expressed as in Fig. 1
A. (B) Relative NFAT activities in untreated or PMA-stimulated Jurkat
cells transfected with Nef. An empty control vector or PLC-DN was
cotransfected as indicated. These data represent mean values   SE from
five independent experiments.
Figure 3. Dependence of NFAT activation by Nef on IP3R function.
(A) Relative NFAT-dependent luciferase expression in Jurkat cells trans-
fected with a control vector or Nef and stimulated with anti-CD3 anti-
bodies or PMA. When indicated, 2-APB was added to the cultures 30
min before their stimulation. (B) Relative NFAT-dependent luciferase
expression in IP3R1-deficient J.IP3R1AS cells transfected with a control
vector or Nef and treated with the indicated activators (anti-CD3, PMA,
and thapsigargin [TG]) as described in Materials and Methods. The data
sets shown are representative of four (A) and seven (B) independent trans-
fection experiments with similar results.1028 Nef and T Cell Calcium Signaling
Recent data have indicated that in addition to its effect
on IP3R, however, 2-APB may also directly inhibit the
function of CRACs at the plasma membrane (48, 49). To
further explore the role of IP3R as an effector of Nef we
used a Jurkat-derived cell line, generated and characterized
by Marks and coworkers, which stably expresses an anti-
sense-RNA for IP3R1 (50) (referred to as J.IP3R1AS cells
in the following). Although the three different types of IP3
receptors (IP3R1, IP3R2, and IP3R3) may have redundant
functions (51), J.IP3R1AS cells, which express only low
levels of IP3R2 and IP3R3, have been demonstrated to be
unable to mobilize calcium and to produce IL-2 after TCR
stimulation (50). By contrast, IP3R-independent depletion
of intracellular Ca2  stores using the sarco-endoplasmic
reticulum Ca2 -ATPase (SERCA) inhibitor thapsigargin
(52) does result in calcium influx also in J.IP3R1AS cells,
indicating that the rest of the machinery involved in
CRAC opening is functional in these cells (50).
In agreement with the previous data from Marks and
coworkers, we found that TCR-mediated activation of
NFAT was abolished in J.IP3R1AS cells, whereas thapsi-
gargin-induced CCE in combination with MAPK activa-
tion (by PMA) elicited a robust increase in NFAT-depen-
dent luciferase expression (Fig. 3 B). More important to the
present study, however, we found that expression of Nef in
PMA-treated J.IP3R1AS cells failed to activate NFAT (Fig.
3 B). Thus, apart from the question whether the effect of
2-APB also involved direct inhibition of CRACs, these re-
sults clearly implicated IP3R1 as an effector molecule of
Nef in activation of calcium signaling.
Nef Associates with IP3R1 in Cells. To examine if the
IP3R1-dependent activation of calcium influx by Nef
would involve a physical interaction between these two
proteins, we examined the presence of Nef in anti-IP3R1
immunoprecipitations from lysates of Jurkat cells and their
IP3R1-deficient derivatives. As shown in Fig. 4 A, readily
detectable amounts of Nef coprecipitated with endogenous
IP3R1 from Nef-transfected but not from control-trans-
fected Jurkat cells. By contrast, despite equal Nef-expres-
sion in J.IP3R1AS cells, no Nef protein could be immuno-
precipitated from these cells using anti-IP3R1 antibodies
confirming that Nef was not precipitated nonspecifically or
because of cross-reactivity of the IP3R1 antiserum. More-
over, Nef/IP3R1 association could be confirmed in a more
physiological experimental system as Nef could also be co-
precipitated by IP3R1 antibodies from lysates of HIV-
infected human peripheral blood mononuclear cells (Fig. 4
B). In addition, IP3R1 and Nef could be coprecipitated
when they were overexpressed together in HEK293 cells,
indicating that this interaction was not restricted to T cells
(Fig. 4 C). Thus, these data show that regulation of IP3R1
function by Nef involves an intracellular protein complex
containing both of these proteins, but of course does not
prove a direct contact between Nef and IP3R1.
Nef-induced Calcium Influx Does Not Involve Depletion of
Cellular Calcium Stores. To examine if binding of Nef to
IP3R1 might mimic the effect of its natural ligand IP3, and
thereby trigger CCE by activating the calcium release
channel function of IP3R1, we compared the filling state of
total ionophore-sensitive as well as IP3-sensitive intracellu-
lar calcium stores in control- and in Nef-transfected Jurkat
cells. In these studies we used a strategy based on cotrans-
fection of an apoaequorin expression vector, which makes
it possible to examine free Ca2  levels only in the positively
transfected subpopulation of cells (38). When the cell-per-
meable luminophore coelenterazine is provided it associates
with the transfected apoaequorin to form an aequorin
complex whose calcium-dependent light emission can be
measured with a luminometer.
The baseline aequorin-luminescence was similar in con-
trol- and in Nef-transfected cells (Fig. 5), which could be
expected because of the relatively lower sensitivity of this
method than the fluorescent method used in experiments
shown in Fig. 1 C. When apoaequorin-expressing cells
were treated with ionophore in nominally calcium-free
medium (in the presence of EGTA), similar amounts of
calcium were released from intracellular stores in control-
and in Nef-transfected cells (Fig. 5 A). However, because
calcium ionophore might release calcium from intracellular
Figure 4. Coprecipitation of IP3R1 and Nef. (A) Control (C) and Nef-
transfected (N) Jurkat and J.IP3R1AS cells were lysed and subjected to
immunoprecipitations using antibodies for Nef (left panel) or IP3R1
(right panel) followed by analysis of the precipitated material by anti-Nef
Western blotting. (B) PBMCs were infected with Nef-negative (Nef( )
HIV) or wild-type (Nef( ) HIV) HIV particles and subjected to anti-Nef
(left panel) or anti-IP3R1 (right panel) immunoprecipitations as described
above. The precipitated material was analyzed by anti-Nef Western
blotting. (C) HEK293T fibroblasts were cotransfected with a control vec-
tor (C) or Nef (N) together with IP3R1 ( IP3R1) or an empty control
plasmid ( IP3R1) as indicated. Cells were subjected to immunoprecipita-
tions as described in 4A and the precipitated material was analyzed by
anti-IP3R1 Western blotting.1029 Manninen and Saksela
compartments with a larger capacity than the IP3-sensitive
stores relevant for T cell activation, we also specifically
measured calcium released from the IP3-gated stores. For
this purpose an expression vector encoding hM1 was
cotransfected with apoaequorin in order to trigger a robust
PLC 1-catalyzed production of IP3 by stimulating these
cells with the hM1 agonist carbachol. As expected, the IP3-
sensitive calcium store contents released by carbachol stim-
ulation were smaller ( 25%) than those released by iono-
phore treatment (Fig. 5). Importantly, Nef did not cause
depletion of the IP3-sensitive calcium stores because the
amount of calcium released upon carbachol treatment was
not reduced, but in fact slightly higher in Nef-expressing
cells than in the control-transfected cells (Fig. 5 B).
In conclusion, no deficits in ionophore- or IP3-sensitive
Ca2  stores were observed in Nef-expressing cells, suggest-
ing that the induction of IP3R1-dependent calcium signal-
ing by Nef did not involve activation of the calcium release
channel function of IP3R. This suggested that Nef acts by
promoting communication between IP3R1 and CRACs in
a manner that leads to increased calcium influx indepen-
dently of the filling state of intracellular calcium stores.
Discussion
In this study we have characterized a novel IP3R-depen-
dent but TCR-independent molecular mechanism
by which Nef may contribute to T cell activation and
HIV replication. It is important to note that this mode
of action is not mutually exclusive with an additional
function of Nef via modulation of TCR signaling previ-
ously described by others (23–25, 53). In fact, such dual
level of regulation of calcium signaling by Nef could be
envisioned to be important in order to ensure continued
T cell activation after downmodulation of TCR func-
tion in Nef-expressing cells (32, 33). Besides facilitating
HIV replication in the infected cell, Nef-induced in-
crease in the activity of NFAT and other calcium-regu-
lated cellular processes could also render the neighbor-
ing cells more susceptible to HIV infection via paracrine
effects of IL-2 and other NFAT-regulated cytokines.
TCR-independent activation of T cell calcium signaling
by Nef was found to involve a physical association between
Nef and IP3R1. Because of the undiminished intracellular
IP3-gated calcium stores in Nef-expressing cells, we con-
cluded that the effect of Nef on IP3R1 did not mimic bind-
ing of IP3, which would lead to CCE via depletion of these
stores. Although it would be difficult to formally exclude
the possibility of depletion of some small and specialized
calcium stores, which despite their insignificant overall ca-
pacity would play a critical role in regulating CCE, our
data suggest that Nef/IP3R1 interaction does not activate
calcium release function of IP3R, but rather promotes a
later step in the chain of events that lead to calcium influx
via CRACs.
The strict dependence of Nef on IP3R function clearly
indicated that Nef did not act by directly modulating the
conductance of CRAC or other plasma membrane calcium
channels. In theory, binding of Nef could induce an alter-
native conformation of IP3R, which would otherwise be
associated with low calcium levels in ER, and thereby trig-
ger the yet unknown mechanism that normally mediates
coupling of ER calcium store depletion to calcium influx.
Alternatively, Nef could play a more direct role in promot-
ing such communication between IP3R and the plasma
membrane CRAC channels. Interestingly, a number of re-
cent studies have suggested that IP3R itself would be phys-
ically involved in this coupling by directly contacting the
SOC/CRAC channels (45–47) (conformational coupling
model). Nef being a multifunctional adaptor known to
modify interactions between host cell signal transducing
proteins (1–3), it is tempting to consider our data as further
support for the conformational coupling hypothesis, and
propose that Nef triggers calcium influx by promoting the
assembly of a complex where protein–protein interactions
would locally connect ER and the plasma membrane and
thereby physically couple IP3R to the relevant CRAC
Figure 5. Comparison of ionophore- and IP3-sensitive intracellular
Ca2 -stores in control and in Nef-expressing cells. (A) Calcium released
from ionophore-sensitive intracellular stores in Jurkat cells cotransfected
with an apoaequorin vector together with a control vector (open squares)
or Nef (black triangles) were measured based on luminescence by Ca2 /
aequorin/coelenterazine complexes in these cells. A similar measurement
of coelenterazine-loaded cells that were not transfected with apoaequorin
is shown as a negative control (dotted line). EGTA and ionophore (Iono)
were added to the cells during the course of the recordings as indicated.
(B) Calcium released from IP3-sensitive stores in Jurkat cells transfected as
in panel A, except that a vector for human muscarinic receptor-1 (hM1)
was also included. EGTA and carbachol (CCh) were added to the cells
during the course of the recordings as indicated. The mean values of qua-
druplicate samples are shown. These measurements were performed 5 (A)
and 10 (B) times with similar results.1030 Nef and T Cell Calcium Signaling
channel(s). As an attempt to address this possibility we have
examined if overexpression of human Trp3, a potential
IP3R-interacting component of SOCs/CRACs (46, 47,
54), would increase Nef/IP3R-complex formation. The re-
sults of these studies were negative (unpublished data),
however, arguing against a simple model where Nef would
stabilize the formation of an IP3R/Trp3 complex. More-
over, it should also be noted here that not all available data
support the conformational coupling model of CCE (12,
49, 55).
Our previous studies have indicated that Src-homology
3 domain (SH3) domain-binding capacity of Nef is re-
quired for its ability to activate NFAT-dependent gene ex-
pression (35). On the other hand, in the course of the
present studies we have noticed that Nef mutants unable to
bind SH3 still retained the capacity to associate with IP3R1
(data not shown). As IP3R1 does not contain an SH3 do-
main, it seems likely that cellular partners of Nef other than
IP3R1 are also recruited to this protein complex and are in-
volved in mediating the effect of Nef on calcium signaling.
Interestingly, Src-kinases, some of which can bind Nef via
their SH3 domains (36), have also been reported to interact
with and regulate the function of IP3R (56–58). Therefore,
we have also considered the possibility that a Src kinase ca-
pable of binding both Nef and IP3R1, such as Hck, could
be involved in the Nef/IP3R-mediated activation of cal-
cium signaling. Based on our previous pharmacological
studies, however, catalytic activity of a Src kinase does not
seem to be involved, because we found that doses of the
Src inhibitor PP1 that fully suppressed TCR-triggered Jur-
kat cell activation failed to prevent Nef-mediated NFAT
activation (34). On the other hand, we have observed no
increase (or decrease) in coprecipitation of Nef and IP3R1
from cells transfected with vectors overexpressing Hck or
Fyn (unpublished data). These observations are in agree-
ment with those by Foti and coworkers, who have exam-
ined the cellular interactions of Hck with Nef and with
IP3R1 (58). Although these authors did not consider the
possibility that Nef and IP3R1 might associate with each
other in a trimolecular or multiprotein complex containing
Hck, their data clearly show that transfection of Nef had no
effect on the association of Hck and IP3R1. Thus, while
common intracellular protein complexes containing Nef,
IP3R1, and a Src kinase might exist, together the data dis-
cussed above do not support the idea that a Src kinase
would play a critical role in bridging Nef and IP3R1, or
that the effect of Nef on calcium signaling would be caused
by targeting Src tyrosine kinase activity to IP3R1.
Because of toxicity of long-term exposure to elevated
levels of cytoplasmic calcium, activation of calcium influx
by Nef might also explain the difficulty of generating T cell
lines that would stably express Nef (e.g., see reference 53).
In line with this hypothesis, we have noticed that stably
Nef-expressing clones of J.IP3R1AS cells cotransfected
with Nef and an eukaryotic selection marker plasmid can
be routinely obtained, whereas it is very difficult to gener-
ate Nef-expressing clones of parental Jurkat cells using the
same approach (unpublished data). It is also of interest to
note that abnormalities in calcium homeostasis, namely in-
creased accumulation of calcium into intracellular stores
(58, 59), have been described in cell lines successfully engi-
neered to stably express Nef, which in the light of our data
could be readily explained as an adaptive response to
chronic Nef expression.
Elucidation of the molecular mechanism that couples
IP3R and SOC/CRAC functions is under active scrutiny
in many laboratories, and represents a major challenge in
understanding of TCR-triggered activation of lymphocytes
and similar calcium-mediated signaling processes in other
nonexcitable cells. Progress in this area of research can also
be expected to provide us with novel molecular tools for
further dissection of the IP3R-dependent mechanism of T
cell activation by Nef. Such information could have valu-
able therapeutic implications, as the mechanistic differences
observed between Nef-mediated and TCR-triggered acti-
vation of T cell calcium signaling suggest that targeting of
this function of Nef could be a promising approach for de-
velopment of novel strategies to interfere with the patho-
genesis of HIV infection. On the other hand, involvement
of Nef in the heart of the apparatus that controls CCE
could also be exploited to gain more insight into this im-
portant process itself.
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